Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Barry J. Byrne

Professor and Associate Chair

University of Florida

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

50%

Virology

30%

Muscular Atrophy

30%

Cardiovascular Risk

20%

Immunomodulation

20%

Gene Therapy

20%

Enzyme Replacement Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles17

Current Clinical Applications of AAV-mediated Gene Therapy.

Article Link

Year:

2025

Overexpression of Wild-Type TMEM43 Improves Cardiac Function in Arrhythmogenic Right Ventricular Cardiomyopathy Type 5

Article Link

Year:

2025

Complement activation in a phase Ib study of fordadistrogene movaparvovec for Duchenne muscular dystrophy

Article Link

Year:

2025

Quantification and comparison of anti-AAV9 and anti-AAVrh74 antibodies in plasma and human milk: Implications for AAV-based gene therapy candidacy

Article Link

Year:

2025

Correction: Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02)

Article Link

Year:

2025

Longitudinal changes of swallowing safety and efficiency in infants with spinal muscular atrophy who received disease modifying therapies

Article Link

Year:

2024

Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02)

Article Link

Year:

2024

Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation

Article Link

Year:

2023

The multifaceted roles of the brain glycogen

Article Link

Year:

2023

Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences

Article Link

Year:

2022

Longitudinal changes in cardiac function in Duchenne muscular dystrophy population as measured by magnetic resonance imaging

Article Link

Year:

2022

Secondary hemophagocytic lymphohistiocytosis following Zolgensma therapy: An evolving story on the innate response to systemic gene therapy

Article Link

Year:

2022

Cardiac responses in paediatric Pompe disease in the ADVANCE patient cohort

Article Link

Year:

2022

Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency

Article Link

Year:

2022

A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen Treatment

Article Link

Year:

2022

Advanced therapeutic strategy for hereditary neuromuscular diseases

Article Link

Year:

2022

Longitudinal Observational Study of Cardiac Outcome Risk Factor Prediction in Children, Adolescents, and Adults with Barth Syndrome

Article Link

Year:

2022

Collaborators9

Rafael J. Jiménez Riobóo

Instituto de Ciencia de Materiales de Madrid

SPAIN

Shinichi Muramatsu

Professor

Jichi Medical University

JAPAN

Barbara Smith

University of Florida

UNITED STATES

Manuela Corti

Associate Professor

University of Florida

UNITED STATES

Ramon Sun

Associate Professor

University of Florida

UNITED STATES

Nicole Paulk

Affiliate, Assistant Professor

UNITED STATES

Matthew Gentry

Professor & Chair

University of Florida College of Medicine

UNITED STATES

Saptarshi Chakraborty

Assistant Professor

University at Buffalo

UNITED STATES

María Villalba Orero

Assistant Professor

Universidad Complutense de Madrid

SPAIN

How do I reach out?

Meet Kite AI